Upregulation of ANKRD13D may affect endocytic trafficking of EGFR by inhibition of its ubiquitinated form from the cell surface, attenuating pro-proliferative signaling of internalized EGFR [59], potentially aggravating AAA. This evidence concerns the gene EGFR and triple-A syndrome.